#AS­CO24: Gilead presents more da­ta on failed Trodelvy lung can­cer study

CHICA­GO — Re­searchers on Fri­day af­ter­noon pulled back the cur­tain on Gilead’s pre­vi­ous­ly an­nounced Phase 3 fail­ure in cer­tain forms of non-small cell lung can­cer. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER